Vaccines for Immune-Mediated Diseases

Patients with safe interceded incendiary ailments (IMID, for instance, RA, IBD or skin problem, square measure at increased danger of contamination, partially in light-weight of the malady itself, but for the foremost half in light-weight of treatment with immune modulatory or immunological disorder medications. in spite of their raised hazard for immunization preventable upset, the immunization scope in IMID patients is shockingly low.

    Related Conference of Vaccines for Immune-Mediated Diseases

    November 03-04, 2025

    19th International Conference on European Immunology

    Rome, Italy
    May 18-19, 2026

    17th Global Summit on Immunology and Cell Biology

    Paris, Aland Islands

    Vaccines for Immune-Mediated Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in